Request Free Sample
×
Industry Developments
Recent developments in the South Korea Radiopharmaceuticals Market indicate a growth-driven environment, primarily attributed to ongoing innovations and regulatory support. Companies like KHIDI and Korea Atomic Energy Research Institute are pushing advancements in the field while ensuring compliance with national health policies. In terms of market dynamics, Posco Holdings and Ilyang Pharmaceutical are notably expanding their portfolios to optimize production capabilities and enhance product offerings. The market has witnessed a significant increase in demand for targeted therapies, bolstered by collaborations among companies such as Daiichi Sankyo and Taejoon Pharmaceutical, focusing on integrating advanced diagnostics with therapeutics. Additionally, mergers and acquisitions are shaping the landscape; for example, in July 2023, Alphamed acquired a key division of Nautilus Biomedical, expanding its radiopharmaceutical capabilities. The market's valuation has been affected positively by these strategic moves, contributing to an encouraging outlook for innovations in diagnostic imaging. Over the last 2-3 years, significant advancements have included the launch of innovative radioisotopes and the establishment of specialized production facilities to meet escalating demand from healthcare institutions across South Korea.
South Korea Radiopharmaceuticals Market Report Scope
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 0.16(USD Billion) |
| MARKET SIZE 2024 | 0.18(USD Billion) |
| MARKET SIZE 2035 | 0.42(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.18% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | KHIDI, Posco Holdings, Ilyang Pharmaceutical, PTG Energy, Daiichi Sankyo, Taejoon Pharmaceutical, Korea Atomic Energy Research Institute, Alphamed, Philips Healthcare, Korea Radioisotope Association, Nautilus Biomedical, Hanmi Pharmaceutical, Bioscience Institute, Lantheus, CURE Pharmaceuticals |
| SEGMENTS COVERED | Type, Application |
| KEY MARKET OPPORTUNITIES | Aging population increasing demand, Advancements in diagnostic imaging, Growth in cancer treatment options, Expansion of nuclear medicine facilities, Government investment in healthcare technologies |
| KEY MARKET DYNAMICS | growing cancer prevalence , technological advancements , increasing elderly population , expanding diagnostic imaging demand , government support and funding |
| COUNTRIES COVERED | South Korea |
Leave a Comment
FAQs
What is the expected market size of the South Korea Radiopharmaceuticals Market in 2024?
The South Korea Radiopharmaceuticals Market is expected to be valued at 0.18 billion USD in 2024.
What is the projected market size for the South Korea Radiopharmaceuticals Market by 2035?
By 2035, the South Korea Radiopharmaceuticals Market is anticipated to reach a valuation of 0.42 billion USD.
What is the expected CAGR for the South Korea Radiopharmaceuticals Market from 2025 to 2035?
The expected CAGR for the South Korea Radiopharmaceuticals Market from 2025 to 2035 is 8.18%.
Which segment of the South Korea Radiopharmaceuticals Market holds a larger value in 2024?
In 2024, the Diagnostic segment of the South Korea Radiopharmaceuticals Market is valued higher at 0.1 billion USD compared to the Therapeutic segment.
What is the projected value of the Diagnostic segment in the South Korea Radiopharmaceuticals Market by 2035?
The Diagnostic segment is expected to grow to 0.22 billion USD by 2035.
What will be the market value of the Therapeutic segment in 2035?
The Therapeutic segment of the South Korea Radiopharmaceuticals Market is projected to be valued at 0.2 billion USD by 2035.
Who are the major players in the South Korea Radiopharmaceuticals Market?
Key players include KHIDI, Ilyang Pharmaceutical, and Posco Holdings among others.
Is there growth potential in the South Korea Radiopharmaceuticals Market?
Yes, the market exhibits significant growth potential due to increasing applications in medical diagnostics and treatment.
What are the key applications driving the growth of the South Korea Radiopharmaceuticals Market?
The key applications include both Diagnostic imaging and Therapeutic treatments.
What are some challenges faced by the South Korea Radiopharmaceuticals Market?
Challenges include regulatory hurdles and high production costs affecting market expansion.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense